WaveMan · Form 4
Groenhuysen Wilhelmus Cm insider trades
> Search tickers & screens ⌘K
LIVE

Groenhuysen Wilhelmus Cm insider trades

Groenhuysen Wilhelmus Cm has filed 23 Form 4s with the SEC that we hold, for NovoCure Ltd (NVCR) (Chief Operating Officer) and OPTN (Director). Across all of them we count 0 purchases worth $0 and 14 sales worth $2.8M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 20,415 shares of NovoCure Ltd worth $1.6M, dated 2023-03-03. The first filing on our record is dated 2021-07-08 and the latest 2025-05-21.

NovoCure Ltd (NVCR)

Chief Operating Officer · 19 filings · 14 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-09-02S, sale reported on Form 4181$25.0K2021-09-07
2022-03-03S, sale reported on Form 41,301$96.9K2022-03-07
2022-03-04S, sale reported on Form 42,569$180.9K2022-03-07
2022-03-08S, sale reported on Form 42,923$204.9K2022-03-09
2022-09-02S, sale reported on Form 4296$23.4K2022-09-06
2023-03-01S, sale reported on Form 42,164$165.2K2023-03-02
2023-03-02S, sale reported on Form 41,213$91.3K2023-03-06
2023-03-03S, sale reported on Form 420,415$1.6M2023-03-07
2023-03-03S, sale reported on Form 41,692$128.9K2023-03-07
2023-03-03S, sale reported on Form 43,528$268.7K2023-03-07
2023-09-01S, sale reported on Form 4294$6.4K2023-09-05
2024-02-28S, sale reported on Form 42,303$37.2K2024-02-29
2024-03-01S, sale reported on Form 42,107$33.8K2024-03-05
2024-03-04S, sale reported on Form 41,217$19.5K2024-03-05

OPTN

Director · 4 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1264783) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms